Biotech Stock Mailbag: Idenix vs. Pharmasset?
Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.
5 Stocks Under $10 With Big Upside Potential
These under-$10 stocks look poised to trade higher from current levels.
Biotech Stock Live Chat
TheStreet's biotech columnist Adam Feuerstein is holding a live, interactive discussion about biotech stock investing.
Neoprobe Stock Gaps Up On Today's Open (NEOP)
Shares of Neoprobe Corporation (AMEX:NEOP) were gapping up Thursday morning with an open price 17.9% higher than Wednesday's closing price. The stock closed at $2.63 yesterday and opened today's trading at $3.10.
Neoprobe Proves A Short Seller Wrong
FDA acceptance of Neoprobe's application for a lymph-node mapping agent is a defeat for a hedge fund manager who waged a campaign to stop the review.
Ford Makes a Major Change
The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.
Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll
Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.
Coinbase Faces A New Scandal
The platform denies selling proprietary customer data and announces it is expanding into several European countries.